Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (9068)	9/9/2003 9:57:02 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 52153

Great research tool. How will you get it to where it's going to work? Is there some reason to "flaunt the lesson of Isis", a lesson learned in 1997?

To: Biomaven who wrote (9068)	9/9/2003 10:11:25 AM
From: Biomaven	Respond to of 52153

After this year's (and in particular yesterday's dramatic) biotech performance it's worth looking a the big picture - and one angle on this is the ratio of the BTK index to the DRG index. This ratio is now 1.54, up from a low of close to 1.0 in early July 2002. (We had a more recent low of 1.28 in July of this year). But the ratio is a long way from the all-time high of 2.6 in March 2000 during the bubble. (In April of 2000 it was back under 1.1) The current levels are very similar to what they were for much of 2001, so there is no indication of bubble-like behavior yet. We are up from 2002 levels, but these were significantly lower than 2000 and 2001 levels. From a longer-term perspective though, biotechs have had a tremendous run - this ratio was only .4 in the depths of the 98 biotech struggles. Peter